139 related articles for article (PubMed ID: 35811174)
1. Unusual suspects in hereditary melanoma: POT1, POLE, BAP1.
Maas EJ; Betz-Stablein B; Aoude LG; Soyer HP; McInerney-Leo AM
Trends Genet; 2022 Dec; 38(12):1204-1207. PubMed ID: 35811174
[TBL] [Abstract][Full Text] [Related]
2. Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families.
Njauw CN; Kim I; Piris A; Gabree M; Taylor M; Lane AM; DeAngelis MM; Gragoudas E; Duncan LM; Tsao H
PLoS One; 2012; 7(4):e35295. PubMed ID: 22545102
[TBL] [Abstract][Full Text] [Related]
3. Expanding the clinical phenotype of hereditary BAP1 cancer predisposition syndrome, reporting three new cases.
Pilarski R; Cebulla CM; Massengill JB; Rai K; Rich T; Strong L; McGillivray B; Asrat MJ; Davidorf FH; Abdel-Rahman MH
Genes Chromosomes Cancer; 2014 Feb; 53(2):177-82. PubMed ID: 24243779
[TBL] [Abstract][Full Text] [Related]
4. A Large Skin-colored Nodule on the Plantar Foot: A Quiz. Melanoma associated with germline BAP1 mutation.
Rojek NW; Korcheva V; Leachman SA
Acta Derm Venereol; 2017 Nov; 97(10):1265-1266. PubMed ID: 28597019
[No Abstract] [Full Text] [Related]
5. CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma.
Betti M; Aspesi A; Biasi A; Casalone E; Ferrante D; Ogliara P; Gironi LC; Giorgione R; Farinelli P; Grosso F; Libener R; Rosato S; Turchetti D; Maffè A; Casadio C; Ascoli V; Dianzani C; Colombo E; Piccolini E; Pavesi M; Miccoli S; Mirabelli D; Bracco C; Righi L; Boldorini R; Papotti M; Matullo G; Magnani C; Pasini B; Dianzani I
Cancer Lett; 2016 Aug; 378(2):120-30. PubMed ID: 27181379
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide.
Walpole S; Pritchard AL; Cebulla CM; Pilarski R; Stautberg M; Davidorf FH; de la Fouchardière A; Cabaret O; Golmard L; Stoppa-Lyonnet D; Garfield E; Njauw CN; Cheung M; Turunen JA; Repo P; Järvinen RS; van Doorn R; Jager MJ; Luyten GPM; Marinkovic M; Chau C; Potrony M; Höiom V; Helgadottir H; Pastorino L; Bruno W; Andreotti V; Dalmasso B; Ciccarese G; Queirolo P; Mastracci L; Wadt K; Kiilgaard JF; Speicher MR; van Poppelen N; Kilic E; Al-Jamal RT; Dianzani I; Betti M; Bergmann C; Santagata S; Dahiya S; Taibjee S; Burke J; Poplawski N; O'Shea SJ; Newton-Bishop J; Adlard J; Adams DJ; Lane AM; Kim I; Klebe S; Racher H; Harbour JW; Nickerson ML; Murali R; Palmer JM; Howlie M; Symmons J; Hamilton H; Warrier S; Glasson W; Johansson P; Robles-Espinoza CD; Ossio R; de Klein A; Puig S; Ghiorzo P; Nielsen M; Kivelä TT; Tsao H; Testa JR; Gerami P; Stern MH; Paillerets BB; Abdel-Rahman MH; Hayward NK
J Natl Cancer Inst; 2018 Dec; 110(12):1328-1341. PubMed ID: 30517737
[TBL] [Abstract][Full Text] [Related]
7. Genotypic and Phenotypic Features of BAP1 Cancer Syndrome: A Report of 8 New Families and Review of Cases in the Literature.
Haugh AM; Njauw CN; Bubley JA; Verzì AE; Zhang B; Kudalkar E; VandenBoom T; Walton K; Swick BL; Kumar R; Rana HQ; Cochrane S; McCormick SR; Shea CR; Tsao H; Gerami P
JAMA Dermatol; 2017 Oct; 153(10):999-1006. PubMed ID: 28793149
[TBL] [Abstract][Full Text] [Related]
8. A new POT1 germline mutation-expanding the spectrum of POT1-associated cancers.
Wilson TL; Hattangady N; Lerario AM; Williams C; Koeppe E; Quinonez S; Osborne J; Cha KB; Else T
Fam Cancer; 2017 Oct; 16(4):561-566. PubMed ID: 28389767
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of germline BAP1 mutation in a population-based sample of uveal melanoma cases.
Aoude LG; Vajdic CM; Kricker A; Armstrong B; Hayward NK
Pigment Cell Melanoma Res; 2013 Mar; 26(2):278-9. PubMed ID: 23171164
[No Abstract] [Full Text] [Related]
10. Germline mutations predisposing to melanoma.
Toussi A; Mans N; Welborn J; Kiuru M
J Cutan Pathol; 2020 Jul; 47(7):606-616. PubMed ID: 32249949
[TBL] [Abstract][Full Text] [Related]
11. BAP1 Syndrome - Predisposition to Malignant Mesothelioma, Skin and Uveal Melanoma, Renal and Other Cancers.
Foretová L; Navrátilová M; Svoboda M; Házová J; Vašíčková P; Sťahlová EH; Fabian P; Schneiderová M; Macháčková E
Klin Onkol; 2019; 32(Supplementum2):118-122. PubMed ID: 31409087
[TBL] [Abstract][Full Text] [Related]
12. Two unique BAP1 pathogenic variants identified in the same family by panel cascade testing.
Byrne L; Ingalls C; Ansari A; Porteus C; Donenberg TR; Sussman DA; Cebulla CM; Abdel-Rahman MH
Fam Cancer; 2023 Jul; 22(3):307-311. PubMed ID: 36513904
[TBL] [Abstract][Full Text] [Related]
13. BAP1 tumor predisposition syndrome case report: pathological and clinical aspects of BAP1-inactivated melanocytic tumors (BIMTs), including dermoscopy and confocal microscopy.
Soares de Sá BC; de Macedo MP; Torrezan GT; Braga JCT; Fidalgo F; Moredo LF; Lellis R; Duprat JP; Carraro DM
BMC Cancer; 2019 Nov; 19(1):1077. PubMed ID: 31706282
[TBL] [Abstract][Full Text] [Related]
14. Association of the POT1 Germline Missense Variant p.I78T With Familial Melanoma.
Wong K; Robles-Espinoza CD; Rodriguez D; Rudat SS; Puig S; Potrony M; Wong CC; Hewinson J; Aguilera P; Puig-Butille JA; Bressac-de Paillerets B; Zattara H; van der Weyden L; Fletcher CDM; Brenn T; Arends MJ; Quesada V; Newton-Bishop JA; Lopez-Otin C; Bishop DT; Harms PW; Johnson TM; Durham AB; Lombard DB; Adams DJ
JAMA Dermatol; 2019 May; 155(5):604-609. PubMed ID: 30586141
[TBL] [Abstract][Full Text] [Related]
15. Clinical Implications of Real-time Integrative Sequencing in Management of Patients With Suspected Germline BAP1 Mutations.
Sengupta S; Weyand AC; Upadhyaya SA; Wu YM; Robinson DR; Mody RJ
J Pediatr Hematol Oncol; 2019 May; 41(4):e263-e265. PubMed ID: 29554022
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Risk of Hereditary Predisposition in Patients With Melanoma and/or Mesothelioma and Renal Neoplasia.
Gupta S; Erickson LA; Lohse CM; Shen W; Pitel BA; Knight SM; Halling KC; Herrera-Hernandez L; Boorjian SA; Thompson RH; Leibovich BC; Jimenez RE; Cheville JC
JAMA Netw Open; 2021 Nov; 4(11):e2132615. PubMed ID: 34767027
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and Preliminary Validation of Screening Criteria to Identify Carriers of Germline BAP1 Mutations.
Zauderer MG; Jayakumaran G; DuBoff M; Zhang L; Francis JH; Abramson DH; Cercek A; Nash GM; Shoushtari A; Chapman P; D'Angelo S; Arnold AG; Siegel B; Fleischut MH; Ni A; Rimner A; Rusch VW; Adusumilli PS; Travis W; Sauter JL; Zehir A; Mandelker D; Ladanyi M; Robson M
J Thorac Oncol; 2019 Nov; 14(11):1989-1994. PubMed ID: 31323388
[TBL] [Abstract][Full Text] [Related]
18. Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1-associated cancer susceptibility syndrome.
Marušić Z; Buljan M; Busam KJ
J Cutan Pathol; 2015 Jun; 42(6):406-12. PubMed ID: 25902915
[TBL] [Abstract][Full Text] [Related]
19. Histologically Diverse BAP1-Deficient Melanocytic Tumors in a Patient With BAP1 Tumor Predisposition Syndrome.
Louw A; Creaney J; Thomas A; Van Vliet C; Harvey NT; Wood BA; Mesbah Ardakani N
Am J Dermatopathol; 2020 Nov; 42(11):872-875. PubMed ID: 32649346
[TBL] [Abstract][Full Text] [Related]
20. Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers.
Abdel-Rahman MH; Pilarski R; Cebulla CM; Massengill JB; Christopher BN; Boru G; Hovland P; Davidorf FH
J Med Genet; 2011 Dec; 48(12):856-9. PubMed ID: 21941004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
